Artron BioResearch Inc.: federal grants and contributions: 8 agreements; $1.7M value; 2 departments; 4 programs.
Assay record ASY-CA-146I8FI0Q7 · Cite as: Assay Systems, “Artron BioResearch Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/artron-bioresearch-inc/
The project is to develop a Lateral Flow Immuno-Assay (LFIA) based COVID-19 IgM/IgG test to detect SARS-CoV-2 IgM and IgG antibody in the blood samples with overall sensitivity>94%, specificity>97%. This device is designed for both professional and/or home-use by serum,plasma as well as fingertip blood sample test. This diagnostic solution will integrate with a mobile application, QR code and cloud network. The innovation will allow for real-time monitoring of COVID-19 spread by transmitting timely data to the public health networks; hence, achieving a low-cost and high-efficiency solution f
To develop a LFIA based SARS-COV-2 Antigen Point-of-Care (POCT) Test to detect SARS-CoV-2 virus from nasopharyngeal swab samples, nasal swab samples or saliva samples collected from patients post symptom onset within the first 7days with sensitivity>95%, specificity>98%, designed for point of care use.
Development of sales and marketing materials
Exhibit at the trade show in MUMBAI in March 2020. Present and publish technical papers. Project and promote the company. Meet existing and potential clients. Make strategic partnerships for business development and initiatives.
Develop digital adoption plan
All grants from Innovation, Science and Economic Development Canada
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.